Skip to main content
. Author manuscript; available in PMC: 2021 Jul 20.
Published in final edited form as: Vaccine. 2020 Jun 5;38(31):4820–4828. doi: 10.1016/j.vaccine.2020.05.057

Fig. 3. Fit of models to the observed data.

Fig. 3.

(Left) Model-predicted and observed monthly incidence of severe RVGE cases among children during both pre- and post-vaccine periods. The vertical line indicates the date of vaccine introduction (April 2012). (Right) Model-predicted and observed proportion of severe RVGE in each age group before and after vaccine introduction. The grey dashed lines separate the pre- and post-vaccination distribution for each age group. The light line region of C indicates model predictions for Navrongo for the period with missing data.